Cosmos Holdings Inc (COSM)
NASDAQ:COSM
Want to see COSM full AI Analyst Report?
COSM Stock Chart & Stats
$0.52
-$0.04(-5.45%)
At close: 4:00 PM EST
$0.52
-$0.04(-5.45%)
Day’s Range― - ―
52-Week Range$0.18 - $1.32
Previous CloseN/A
Volume59.12K
Average Volume (3M)1.18M
Market Cap
$13.22M
Enterprise Value$31.91M
Total Cash (Recent Filing)$548.93K
Total Debt (Recent Filing)$17.42M
Price to Earnings (P/E)―
Beta1.94
Next Earnings
Aug 24, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.66
Shares Outstanding62,078,396
10 Day Avg. Volume1,246,475
30 Day Avg. Volume1,183,471
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.82
Price to Sales (P/S)0.23
P/FCF Ratio-1.77
Enterprise Value/Market Cap2.41
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit4.42
Enterprise Value/Ebitda-1.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.08
Revenue Forecast (FY)$103.20M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthRobust trailing‑twelve‑month revenue (~$69.5M) and ~29.8% revenue growth indicate durable market demand and expanding distribution reach. Persistent top‑line expansion provides a runway to leverage fixed costs, invest in systems, and pursue higher‑margin lines over months.
Improved Financial LeverageLower leverage (debt/equity ~0.48) and positive equity materially reduce refinancing and solvency risk versus 2025. This stronger balance sheet footing improves financial flexibility to fund operations or M&A without immediate refinancing pressure, aiding medium‑term stability.
Business Model: B2B Pharma DistributionA B2B pharmaceutical distribution model serving pharmacies, hospitals and institutional buyers is structurally sticky and recession‑resilient. Recurring wholesale relationships and product essentiality support stable demand and predictable revenue streams over the coming quarters.
Bears Say
Persistent Negative ProfitabilityThin gross margins and deeply negative operating/net margins show the current scale and cost structure fail to convert sales into profits. Without sustained margin expansion or higher‑margin products, losses will likely persist and impede durable earnings improvement.
Negative Operating And Free Cash FlowConsistent cash burn (OCF and FCF both negative) means the business consumes cash rather than self‑funding growth. Over 2–6 months this raises reliance on external financing, heightens dilution or refinancing risk, and limits capacity to invest in margin improvement.
Negative Returns / Value ErosionA negative return on equity indicates the company is destroying shareholder capital despite positive equity. Persistent negative returns signal structural issues in converting capital into profitable growth and present a long‑term recovery challenge absent sustained profitability.
Cosmos Holdings News
COSM FAQ
What was Cosmos Holdings Inc’s price range in the past 12 months?
Cosmos Holdings Inc lowest stock price was $0.18 and its highest was $1.32 in the past 12 months.
What is Cosmos Holdings Inc’s market cap?
Cosmos Holdings Inc’s market cap is $13.22M.
When is Cosmos Holdings Inc’s upcoming earnings report date?
Cosmos Holdings Inc’s upcoming earnings report date is Aug 24, 2026 which is in 64 days.
How were Cosmos Holdings Inc’s earnings last quarter?
Currently, no data Available
Is Cosmos Holdings Inc overvalued?
According to Wall Street analysts Cosmos Holdings Inc’s price is currently Overvalued.
Does Cosmos Holdings Inc pay dividends?
Cosmos Holdings Inc does not currently pay dividends.
What is Cosmos Holdings Inc’s EPS estimate?
Cosmos Holdings Inc’s EPS estimate is 0.01.
How many shares outstanding does Cosmos Holdings Inc have?
Cosmos Holdings Inc has 62,078,396 shares outstanding.
What happened to Cosmos Holdings Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cosmos Holdings Inc?
Currently, no hedge funds are holding shares in COSM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cosmos Holdings Inc
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
Technical Analysis
Ownership Overview
25.46% Insiders
0.49% Mutual Funds
<0.01% Other Institutional Investors
73.77% Public Companies and
Individual Investors